Fecal Lactoferrin Testing

Affiliations

¹ Associate Professor of Clinical Medicine, Weill Cornell Medical College Adjunct Associate Professor of Internal Medicine, Texas A&M University College of Medicine Director, Gastroenterology Fellowship Program, Houston Methodist Director and Distinguished Professor, Fondren Inflammatory Bowel Disease Program, David M. Underwood Center of Digestive Disorders Houston, Texas.

Bincy P Abraham. Gastroenterol Hepatol (N Y). 2018 Dec.

. 2018 Dec;14(12):713-716.

¹ Associate Professor of Clinical Medicine, Weill Cornell Medical College Adjunct Associate Professor of Internal Medicine, Texas A&M University College of Medicine Director, Gastroenterology Fellowship Program, Houston Methodist Director and Distinguished Professor, Fondren Inflammatory Bowel Disease Program, David M. Underwood Center of Digestive Disorders Houston, Texas.

No abstract available

References

1. Abraham BP, Kane S. Fecal markers: calprotectin and lactoferrin. Gastroenterol Clin North Am. 2012;41(02):483–495. - PubMed
1. Barré A, Tarassishin L, Eisele C et al. Faecal lactoferrin is a reliable IBD biomarker during pregnancy [abstract P160] J Crohns Colitis. 2018;12(01):S178. Supplement.
1. Buderus S, Boone JH, Lentze MJ. Fecal lactoferrin: reliable biomarker for intestinal inflammation in pediatric IBD. Gastroenterol Res Pract. 2015;2015:578527. - PMC - PubMed
1. Klimczak K, Lykowska-Szuber L, Eder P et al. The diagnostic usefulness of fecal lactoferrin in the assessment of Crohn’s disease activity. Eur J Intern Med. 2015;26(08):623–627. - PubMed
1. Koslowsky B, Livovsky DM, Goldin E, Bar-Gil Shitrit A. Fecal lactoferrin levels are stable during pregnancy [abstract P307] J Crohns Colitis. 2017;11(01):S233. Supplement.